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Influenza A virus neuraminidase (NA), a type II transmembrane glycoprotein plays a role in 
the cleavage of sialic acids and facilitating the release of mature virions from the surface of 
infected cells. NA has also previously been shown to play a role in virion formation during 
influenza A virus budding, although the exact mechanisms by which NA contributes to 
influenza virion formation and morphology is currently unknown. Previous research has 
shown that mutations within the transmembrane domain (TMD) of NA can result in 
alteration in virion morphology, particularly in the production of filament like influenza 
virions. In this research project we examined if the TMD does indeed play a role in influenza 
virus budding and morphology. We utilised both full and partial mutations of the TMD of NA 
from A/WSN/33, a primarily spherical lab adapted influenza strain, with the TMD of a 
primarily filamentous strain A/California/09. To evaluate the effects of TMD on the 
morphology of a primarily spherical strain with that of filamentous strain. This study used a 
transfection based virus like particle (VLP) system to examine the effects of TMD alterations 
on morphology, utilising various biochemical and microscopy methods. Our findings show 
that as previously indicated mutations within the TMD do result in alterations to virion 
morphology, as well as showing that despite previous theories both NA and NA’s TMD may 





HEK 293T cells – Cambridge Human embryonic Kidney 293 T cells 
AMP – Ampicillin  
CaCL – Calcium Chloride  
Dmem + 10% FBS – Dulbeccos modified eagles medium with 10% Fetal bovine serum 
E. coli – Escherichia Coli 
HA – Hemagglutinin 
HindIII  –  Restriction enzyme cutting pCAGGS plasmid  at 2275 base pairs 
Kan – Kanamycin  
LB – Lysogeny Broth 
M1 – Influenza matrix protein 1 
M2 – Influenza matrix protein 2  
NA – Neuraminidase 
NP – Nucleoprotein 
NS1–Non structural protein 1 
NS2–Non structural protein 2 
PA– Influenza viral polymerase molecule 
PB1– Influenza viral polymerase molecule 
PB2– Influenza viral polymerase molecule 
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PBS– Phosphate buffered saline 
Pen– Penicillin 
RNA– Ribonucleic acid  
RNP– Ribonucleoprotein  
SDS Page– Sodium dodecyl sulphate polyacylamide gel electrophoresis 
SOC– super optimal broth with catabolite repression 
Strep– Streptomycin  
TEM– Transmission electron microscopy  
VLP– Virus like particle(s) 
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The influenza virus is a member of the viral family orthomyxoviridae, both pandemic and 
seasonal variations of the virus are responsible for worldwide outbreaks of respiratory and 
gastrointestinal illness. Seasonal flu accounts for around 250,000 to 500,0001 deaths alone, 
with those most at risk being the young, old and immune compromised, due to 
complications such as secondary infections. Continuous evolution and mutation of the 
influenza virus leads to the production of seasonal and pandemic strains of the influenza 
virus. The classification of influenza virus is dictated by the type of hemagglutinin (HA) and 
neuraminidase (NA) surface glycoprotein expressed on the surface of the mature virus. It is 
these two surface glycoproteins HA and NA which are recognised by the immune system 
and responsible for a person’s immunity to the varying strains of the influenza virus. 
Seasonal strains of the virus are the result of “antigenic drift”2. Antigenic drift is due to a 
number of minor mutations within HA and NA, resulting in the production of a virus that is 
similar in phenotype to its predecessor, but due to minor mutations in HA and NA has a 
different antigenic profile. This difference in antigenic profile means that on average within 
a given population there will be low previous immunity to the virus. It is this process of 
antigenic drift which requires the continuous surveillance of influenza strains within a 
population, and the updating and production of a new influenza vaccine yearly.  
Pandemic strains are the result of a process known as “antigenic shift”3, where up to three 
different strains of the influenza virus infect the same host. During replication there is a 
genetic mixing of segmented viral genome leading to the production of new virus, which has 
a novel combination of HA and NA surface proteins not seen in the current repertoire of 
influenza viruses within the host population. Typically the novel composition of the surface 
glycoproteins of the pandemic strain will differ widely from the seasonal strains within the 
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current population, this results in the production of a strain where there is no previous 
immunity to the virus within the population, and where immunisation strategies at the time 
of emergence are ineffective at providing any immunity or protection from the virus. 
Leading to the rapid spread of the virus and high mortality within those infected,  the best 
know historical example of this is the 1918 H1N1 “Spanish flu” pandemic that spanned the 
globe and resulted in 50 million deaths over a two year period4. 
The influenza virus is a member of the viral family orthomyxoviridae made up of three 
different categories of influenza viruses, A, B and C all of which cause pathogenesis in 
humans1. The typical structure of influenza virus is a filamentous or spherical virion.  The 
typical anatomy of an influenza virion (Figure 1) is a lipid capsule surrounding the capsid and 
RNA nucleoprotein core of the virus. The viral glycoprotein’s hemagglutinin (HA) and 
neuraminidase (NA) span the outer lipid membrane of the mature influenza virion, and are 
involved in initiating virus entry into a host cell5,6. Matrix protein 1 (M1) forming a second 
layer of the virion connecting the outer lipid bilayer and ribonucleoprotein core7 (RNP). Matrix 
protein 2 (M2) is a proton selective ion channel, and is involved in balancing the pH across 
viral membrane during entry into the host cell and viral replication8,9. The ribonucleoprotein 
core consists of the viral nucleoprotein (NP) that is involved in packing the viral genome during 
budding and replication, as well as RNA polymerase complex proteins PA, PB1 and PB210,11. 
Other proteins are involved in process of replication but are not found in the mature virion 
such as non-structural protein 1 (NS1)12 involved in evasion of the host immune system , non-
structural protein 2 (NS2)13 or nuclear export protein involved in exportation of the viral 
proteins form host cell’s nucleus. And PB1-F211 which is involved in causing apoptosis of the 
virally infected cell, although PB1-F2 is not found in all strains of the influenza virus. Eight of 







Viral budding and virion morphology 
The process of budding is where a mature influenza virion is assembled and released form 
an infected cell. Based on recent research, the currently proposed model of budding14 is 
thought to be initiated by glycoproteins HA and NA being transported and expressed on the 
surface of infected cell. HA and to a lesser extent NA are thought to cause recruitment and 
concentration of lipids raft domains in the cell membrane into high concentration lipid raft 
domains called the viral budozone15 5. This clustering of lipid raft domains is thought to 
initiate membrane curvature and recruit M1 to newly budding virion.  M1 then polymerases 
through binding to cytoplasmic tails (CT) of HA and NA, this polymerisation results in further 
membrane curvature and formation of budding immature virion. The polymerisation of M1 
is thought to act as a binding site for RNP and NP, which in inhibits M1’s ability to alter 
membrane curvature.  The Binding of M1 is thought to also recruit M2 to low lipid area at 
Fig1: Cartoon depicting the typical structure of a mature spherical influenza virion adapted from 37. 
Showing two surface glycoproteins hemagglutinin (HA) in blue and neuraminidase (NA) in orange. 
Matrix protein 1(M1) and matrix protein 2 (M2) in green. And a depiction of segmented viral 
genome and ribonucleoprotein core. 
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the base of budding virion between virion and cell membrane, caused through the depletion 
of high lipid raft domains through the concentration of these areas by HA and NA. This 
depletion of lipid raft domains allows M2 to insert its amphipathic helix into cell membrane, 
causing tension change between lipid phase and resulting in lipid packing defects within the 
membrane, resulting in positive membrane curvature 16. This positive membrane curvature 
is thought to be powerful enough to allow the pinching, membrane scission and release of 






Mature influenza virions can exist in two distinct morphologies, either a round spherical 
virion or long filamentous virion. Spherical virions typically measure 100 nanometers (nm) in 
Fig 2: Proposed model of budding and release of mature influenza virion Adapted from Rossman et 
al 2011 14. Section (A) demonstrating HA (Red) and NA (Orange) causing the clustering of lipid raft 
domains into viral budozone, causing membrane curvature and initiation of budding. (B) showing 
the continuation of budding through recruitment and binding of M1 (purple) to the  CT of HA and 
NA. Polymerisation of M1 causing the recruitment of RNP core and viral genome into the budding 
virion. (C) Demonstrating the recruitment of M2 (Blue) by M1 into the low cholesterol area at the 
base of budding virion known as the neck. Where M2 inserts its amphipathic helix resulting in 
positive membrane curvature and membrane scission resulting in the pinching off and release of 
mature virion from the infected cell. (D) Showing the overall process of budding from coalescence of 




size and are found mainly in primary isolates, lab adapted strain and in some clinical 
samples. Mature filamentous virions are typically pleomorphic in shape, measuring up to 30 
µm in length and 100nm in diameter. Filamentous virions are typically found in samples 
taken from clinical isolates. Despite varying differences in size and morphology of two 
virions previous research has found that filamentous virions possess similar expression of 
viral proteins and no observable differences in the structure of viral genome compared to 
spherical virions 17. 
The reason for these two distinct morphologies along with the exact mechanisms behind 
budding, the exact mechanism that control or select for the expression of filamentous or 
spherical virions are not yet fully understood.  It was previously theorised that filamentous 
or spherical morphology may aid in the transmissibility of virion or confer some survivability 
traits which may help the virion survive outside host or infect another host. Numerous 
studies have found very little significant difference between the transmissibility or 
infectiousness of different virion morphologies18. Another theory is that spherical or 
filament formation may be a result of adaption to a growth in a specific host. As it has been 
repeatedly observed since the 1960’s that repeated passaging of a primarily filamentous 
isolates in eggs result in the loss of filamentous morphology 19 20.  
As mentioned above the exact mechanisms behind filament formation are currently 
unknown, but there has been a large amount of research into discovering the exact 
mechanisms budding with viral proteins M1 21,22, HA,NA23 5 13 24 and M2 21 25 being thought 




Neuraminidase and its role in virus morphology 
NA is a tetramic type II membrane glycoprotein, responsible for the enzymatic cleavage of 
sialic acid residues promoting release of newly formed virion from surface of infected cell 
and preventing the aggregation of virions during budding and release of budding virions26. 
The basic structure of NA consists of four distinct parts, enzymatic head domain which gives 
NA its characteristic mushroom like structure, responsible for its enzymatic activity. Variable 
stalk, thought to regulate the height of head domain in accordance to cell surface receptor 
height which along with the head region makes up the ectodomain. Also containing the 
transmembrane domain (TMD) anchoring NA to viral membrane and highly conserved 






Fig 3: Typical structure of Influenza A type II 
transmembrane glycoprotein neuraminidase (NA) 
shows stereotypical “mushroom” like shape. Consisting 
of the ectodomain made up of enzymatic head domain 
responsible for cleavage of sialic acid, and the variable 
stalk region.  Adapted from Da silva et al 2013 30 
Also consists of transmembrane domain shown to be 
involved in assembly of NA head domain. And Highly 




NA has on numerous occasions been shown to play a more direct role in budding than 
previously thought. With studies and previous work in our laboratory 5 27 showing that in 
plasmid based virus like particle systems (VLP) NA is not only able to induce membrane 
curvature and produce virus like particles from transfected cells. But is also able to facilitate 
the release of these virus like particles from the surface of transfected cells. And that NA is 
also seemingly capable of producing both spherical and filamentous VLP’s in these plasmid 
based system, conferring that NA may play a more direct role than previously thought.   
In terms of exact mechanism of NA’s role in budding and virus morphology a large volume of 
previous studies have been directed towards the enzymatic head domain of NA, due to the 
conserved nature of TMD and CT amino acid sequences amongst differing strains and 
morphologies, the latter being highly conserved. Because of this the TMD has been 
relatively understudied. 
 
Transmembrane domain role in NA structure and function 
Despite the lack of study several studies that have been done to explore the role of TMD 
both towards NA’s involvement in budding and towards the assembly and structural 
properties that TMD confers within NA have shown several key findings. 
Research 28 29 has shown that TMD can play a role in virus morphology. In the referenced 
studies it was found that when various mutations within the TMD of influenza A virus strain 
A/WSN/33 a classically spherical strain were made, that these mutations resulted in 
significant alterations in virus morphology upon infection of Madin- Δarby canine kidney 
cells (MDCK).  These findings suggest that the TMD may play a direct role in virus 
morphology or may affect the assembly of NA in a way that alters virus morphology.  
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Very recent studies 30,31 have shown that the TMD may play a more predominant role than 
previously thought. This study found when NA was expressed without its TMD NA was 
synthesised and transported to the plasma membrane correctly, but resulted in an inactive 
form of NA. Inactive NA was able to be rescued through the truncation of variable stalk 
region of inactive NA indicating that the TMD contributes and is required for NA maturation 
by effectively tethering the stalk to membrane allowing NA head domain to further drive 
assembly31. 
The study also found that varying polar residues and faces found within the TMD directly 
affect seemingly dictate the assembly of TMD from a dimer to a tetramer. With the study 
highlighting two distinct polar faces A and E faces of TMD that were found to be expressed 
adjacently across the NA subgroups N1, N3-N9 (S1), with the exception of N2 that was found 
not to have these widely conserved adjacent polar faces. And that these differences in 
localisation and interactions of various polar faces lead to differences in both the strength of 
interaction between TMD assembly and varying hydrophobicity of TMD, which is thought to 
result in alterations in TMD insertion and interaction with the plasma membrane (S1,S2). 
Indicating that the TMD may drive assembly along with enzymatic head domain through its 
anchorage of stalk region during insertion and formation of NA, along with alterations 
within the structure of the TMD may cause differing strength of interactions between NA 
and plasma membrane. 
Based on these recent findings this research project aimed to explore the potential effect 
that the TMD and variation within the assembly of TMD have on the ability of NA to 
facilitate budding and its effect of virus morphology. As well as trying to further elucidate 
the role of NA in the process of influenza virus budding and potential interactions that take 
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place. Utilising a plasmid based virus like particle system along with other various 






















HEK 293T cells were maintained in Dulbecco’s modified eagles medium (DMEM) (Sigma) 
supplemented with 10% fetal bovine serum (FBS) (Sigma), also containing 100 units/ml 
penicillin (Pen) and streptomycin (Strep). In a humidified incubator (Thermofisher) at 37 
degrees and 5 % CO2.  
Plasmids 
Both sets of plasmids pcDNA1.3  and NA76 Delta G 1.3 pcDNA3.1A sets of NA plasmids were 
kindly produced by Robert Daniels (University of Stockholm). Created through polymerase 
chain reaction (PCR) overlap cloning of pcDNA3.1A plasmid (Invitrogen) attached to a C 
terminal Myc-His Tag. Containing full length NA from H1N1 strain A/WSN/33. 
Competent cells 
A single colony of Top 10 Escherichia Coli (Invitrogen) were inoculated into lysogeny broth 
(LB) liquid medium and shaken at 37 degrees for 12 hours. 1ml of incubated culture was then 
in 100ml of LB medium and shaken at 37 degrees for 2 hours or until it reached an OD of 0.25 
-0.3 at an OD600. Culture was then chilled on ice and centrifuged for 10 minutes at 3300 g at 
4.C , supernatant discarded and resuspended in 40ml of 0.1M CaCL and placed in ice for 30 
minutes. Cells were then centrifuged again at 3300 g at 4.C for 10 minutes and resuspended 
in 6ml of 0.1M CaCL and 15% glycerol solution (filter sterilised). 0.2ml of culture frozen at -70 
degrees for a maximum of two months. 
Recovery, transformation and extraction of plasmid stocks 
Plasmid stocks recovered from filter paper via being soaked in 25µl of tris-EDTA (TE) buffer 
(Qiagen) and spun at max speed in a table top centrifuge (Thermo fisher) for 5 minutes. 
After which both sets of described plasmids were transformed using a heat shock 
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transformation method. Frozen competent cells thawed at room temperature for 10 
minutes, with 10µl of suspended plasmid + TE buffer solution being added to 50µl of 
competent cells. Cells incubated on ice for 30 minutes, after which cells heat shocked at 42 
degrees in a drybath (Thermo fisher) for 2 minutes. Placed on ice for a further 5 minutes 
before 60µl culture being placed in 940µl of LB, incubated at 37 degrees and 200 revolutions 
per minute(rpm) for 1 hour in a shaking incubator. Inoculated media then diluted 100 fold 
and 100µl plated on LB+Amp plates incubated at 37 degrees for 16 hours. 
After transformation transformed cells scaled up through inoculation of 1 colony in 5ml of 
LB+Amp and incubated at 37 degrees and 200 rpm for 8 hours in a shaking incubator. 100µl 
of inoculated culture placed in 150ml of LB+Amp and incubated at 37 degrees and 200 rpm 
for 16 hours or until an optical density of 0.600 at 600 nanometers-1(nm). Plasmids purified 
and recovered through Gen elute HP plasmid maxiprep kit (Sigma) as per manufactures 
instructions. Plasmid yield ascertained through nano drop spectrophotometer (thermo 
fisher) as per manufacture protocol.  
Purified plasmids were checked for NA through a restriction digest on 1% agarose gel run at 
90v and 180 amps using 1KB DNA ladder (Invitrogen) and 5x standard sample buffer in a 
novex gel tank (Invitrogen).  
 
Analysis of VLP morphology 
HEK 293T cells were seeded in 6 well dishes containing coverslips. Coverslips soaked in Poly-
L-Lysine (Thermofisher) for 3 hours and rinsed 4 times before use.  Cells were grown in 2ml 
DMEM-10%FBS +Pen/Strep for 16 hours at 37 degrees and 5% CO2 until 60 % confluent. 
Cells were transfected using TransIT – 293 transfection reagent (Mirus) according to 
manufactures protocol, with 5µg of desired plasmid.  
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Cells incubated for 48 hours post transfection at 37 degrees and 5% CO2, culture medium 
removed and transfected coverslips placed in 2ml of 10%formalin-Phosphate buffered saline 
(PBS) for 10 minutes. Coverslips were rinsed in 2ml PBS twice and edges aspirate, after 
which 200µl of blocking solution (DMEM + FBS) added to surface of each coverslip and 
incubated for 20 minutes. 200µl of primary antibody Myc tag mouse monoclonal antibody 
9B11 (Cell Signal) at a 1 in 1000 dilution in blocking solution added to the surface of each 
transfected coverslip. Primary antibody incubated for 1 hour, after which primary antibody 
removed and coverslips rinsed 4 times in 2ml PBS.  
200µl of secondary antibody Donkey anti mouse fluorescently tagged with Alexa 488 (Life 
technologies) in a 1:400 dilution in blocking media was added to the surface of each 
coverslip and was incubated for 1 hour in the dark.  The coverslips were then washed four 
times in 2ml PBS, blot dried and mounted in 12µl of prolong gold for 12 hours. Mounted 
coverslips were imaged using a Leica immunofluorescence confocal microscope using Leica 
operating software.  
 
Analysis of Lipid raft formation 
HEK 293T cells were seeded in 6 well dishes containing coverslips. Coverslips soaked in Poly-
L-Lysine (Thermofisher) for 3 hours and rinsed 4 times before use.  Cells were grown in 2ml 
DMEM-10%FBS +Pen/Strep for 16 hours at 37 degrees and 5% CO2 until 60 % confluent. 
Cells were transfected using TransIT – 293 transfection reagent (Mirus) according to 
manufactures protocol, with 5µg of desired plasmid.  
Cells incubated for 48 hours post transfection at 37 degrees and 5% CO2, culture medium 
removed and coverslips placed in 2ml of DMEM+FBS with 2µl of fluorescent cholera toxin B 
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(CT-B) conjugate labelled with Alexa 488 and incubated for 10 minutes at 4 degrees. After 
incubation coverslips washed 2 times in chilled 1x PBS and placed in 2ml of DMEM+FBS 
containing 10ul of Anti CT-B antibody, incubated at 4 degrees for 15 minutes. In order to 
allow visualisation of lipid raft domains. 
Transfected coverslips placed in 2ml of 10%formalin-Phosphate buffered saline (PBS) for 10 
minutes. Coverslips were rinsed in 2ml PBS twice and edges aspirate, after which 200µl of 
blocking solution (DMEM + FBS) added to surface of each coverslip and incubated for 20 
minutes. 200µl of primary antibody Myc tag mouse monoclonal antibody 9B11 (Cell Signal) 
at a 1 in 1000 dilution in blocking solution added to the surface of each transfected 
coverslip. Primary antibody incubated for 1 hour, after which primary antibody removed 
and coverslips rinsed 4 times in 2ml PBS. 200µl of secondary antibody Donkey anti mouse 
fluorescently tagged with Alexa 594 (Life technologies) in a 1:400 dilution in blocking media 
added to the surface of each coverslip and was incubated for 1 hour in the dark.  The 
coverslips were then washed four times in 2ml PBS, blot dried and mounted in 12µl of 
prolong gold for 12 hours. Mounted coverslips were imaged using a Leica 
immunofluorescence confocal microscope using Leica operating software.  
 
VLP expression levels 
HEK 293T cells were seeded in 6 well dishes containing coverslips. Coverslips soaked in Poly-
L-Lysine (Thermofisher) for 3 hours and rinsed 4 times before use.  Cells were grown in 2ml 
DMEM-10%FBS +Pen/Strep for 16 hours until 60 % confluent. Cells were transfected using 




Transfected cells incubated for 48 hours, after which supernatant extracted and 
concentrated to 30x concentration using Amicon Ultra 0.5 centrifugal concentrators 
(Millipore) as per manufactures specifications. Supernatant mixed with lysis buffer ( Bolt LDS 
sample buffer (Invitrogen) and 500mM DTT) in a 1:5 lysis buffer: sample  ratio.  
Transfected cells were lysed using 250µl of Bolt LDS sample buffer, sheared using a needle 
and diluted in 1:10 dilution with lysis buffer solution. Samples heated at 90 degrees for 10 
minutes in a drybath (Thermofisher).  Samples run on a Bolt 4-12% Bis Tris plus 15 well 
precast gel (Novex) with sea blue 2 prestained ladder (Novex), run using a Bolt mini gel tank 
(Novex) as per manufacture protocol at 165 volt, 200 amps for 30 minutes. Gel 
electrophoresis transferred to membrane through iBlot dry blotting system (Invitrogen) as 
per manufactures protocol. Transferred membrane stained using western breeze 
chromogenic immunodetection kit (Invitrogen) as per manufacture protocol, stained with a 
primary antibody primary antibody Myc tag mouse monoclonal antibody 9B11 (Cell Signal) 
at a 1 in 1000 dilution. After which stained with a secondary antibody donkey anti mouse 
provided within the kit. Air dried for 12 hours and electronically scanned for analysis and 









Neuraminidase is able to facilitate budding in a VLP system and influence VLP morphology 
NA has been shown previously to be able to induce budding and formation of a VLP when 
expressed in a VLP system, it has also been shown that NA has a role in influencing VLP and 
virus morphology. To test this we examined the effects of NA of NA from a lab adapted 
spherical strain A/WSN/33 and a lab adapted filamentous strain A/Udorn/72 to see if NA is 
able to facilitate budding and confers any control of VLP morphology.  
To investigate this plasmids containing either NA from A/WSN/33 or A/Udorn/72 were 
transfected into 293T HEK cells, incubated for 48 hours, fluorescently stained and imaged 
via immunofluorescence confocal microscopy to determine any budding activity and 










The results of this investigation showed as already suggested that NA is able to facilitate 
budding in a VLP system (Fig 4).  Confocal imaging of NA of A/WSN/33 (Fig 4A) resulted in 
formation of bulges in cell membrane and  fluorescent dot like staining on the cell surface 
known as puncta32 indicating the formation and production of spherical VLP’s.  Confocal 
imaging of NA of primarily filamentous strain A/Udorn/72 resulted in budding of VLP from 
Fig 4:  Comparison of HEK 293T cells transfected with NA from A/Udorn/72 and A/WSN/33 to assess 
NA’s ability to facilitate VLP budding and examine the morphological differences between a primarily 
spherical and filamentous NA. 
(A)Top panel showing HEK 293T cells transfected with NA of A/Udorn/72, transfected and incubated 
for 48hrs, labelled and stained with alexa 488 antibody imaged via confocal microscopy. Showing 
significant filament like VLP formations protruding form surface of transfected cells indicated by the 
white arrows showing filamentous VLP budding from cell membrane. Showing NA’s ability to facilitate 
the budding and production of filamentous VLP’s. Images taken by C Wilson of the Rossman 
laboratory, University of Kent. 
(B) Bottom panel showing HEK 293T cells transfected with NA of A/WSN/33, transfected and 
incubated for 48hrs, labelled and stained with alexa 488 antibody imaged via confocal microscopy. 
Showing formation of puncta as indicated by white arrow showing dot like staining on surface of 
transfected cells indicating the production of spherical VLP’s. Scale bar indicating 21µm. 
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surface of transfected cells (Figure 4B), but also revealed VLP’s with a distinctly filament like 
structure seen widely budding from surface of cells across all transfected samples as we 
previously seen within our laboratory (data not shown). 
 
Alterations in the transmembrane domain of neuraminidase result in changes in virus like 
particle morphology 
As shown in figure 4 NA is able to confer varying morphological traits when expressed, 
previous research 28 has also shown that mutations within the TMD can result in differing 
changes in virus morphology. To elucidate if the TMD is responsible for morphological 
characteristics of NA or confers any ability to alter membrane curvature, PCR overlap 
cloning was used to replace the TMD of A/WSN/33 NA (WT WSN) with the TMD of the 
primarily filamentous pandemic A/California/09 NA (WSN-PN1) (Gifted by Dr R Daniels, 
University of Stockholm). A/California/09 strain was chosen as both are N1 subgroup of NA, 
but have various differences in amino acid sequence structure of their TMD. The TMD of 
A/California/09 has also been found to have a higher hydrophobicity and weaker polar 
interactions compared to that of other NA N1 strains such as A/WSN/3330.  
Both pcDNA3.1A-myc-his tagged plasmids were transfected into 293T HEK cells, incubated 
for 48 hours, stained and imaged via immunofluorescence confocal microscopy to analyse 
VLP morphology. Repeats of transfection of WT WSN NA through confocal microscopy  (Fig 
5) confirmed the ability A/WSN/33 NA to induce budding and produce spherical VLP’s, 
through strong indication of puncta like staining on the surface of transfected cells. 
Examination of the replacement of TMD of A/WSN/33 NA with that of A/California/09 NA 
(WSN-PN1) through confocal imaging revealed the production of filament like VLP’s on the 









Differing hydrophobicity of fully assembled transmembrane domain do not alter virus like 
particle morphology.  
Recent research 30 has suggested that the NA TMD interactions are linked to hydrophobicity 
of the TMD residues in terms of TMD assembly and interaction of polar faces with the TMD. 
To explore the possibility that these specific polar faces and the hydrophobicity of NA TMD 
alter interactions and if these interactions have any effect of VLP morphology, several 
plasmid constructs kindly provided by Robert Daniels at University of Stockholm were 
utilised. Three distinct sets of mutations were made in the NA TMD residues responsible for 
three distinct polar faces of WSN-PN1 plasmid through PCR overlap cloning. Mutations were 
Fig 5: (A) top row showing HEK 293T cells transfected with plasmid vector pcDNA3.1A myc-his tag 
expressing A/WSN/33 NA, incubated for 48 hours at 37 degrees and 5% CO2, stained, fixed and 
imaged by immunofluorescence confocal microscopy.  Showing characteristic puncta like staining on 
surface of transfected cells indicating the production of spherical virus like particles. Scale bar 
(white) of 23µm. 
(B) Bottom row showing HEK 293T cells transfected with plasmid vector pcDNA3.1A myc-his tag 
expressing A/WSN/33 NA with the TMD of A/California/09 strain (WSN-PN1), incubated for 48 hours 
at 37 degrees and 5% CO2, stained, fixed and imaged by immunofluorescence confocal microscopy. 
Showing long filament like particles protruding from the surface of transfected cells. These filament 
like structures are characteristic and similar to that in morphology of confirmed filamentous virions 
and VLP’s seen in previous literature. 
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made through alanine substitutions in TMD in the residues responsible for conserved 
adjacent A polar faces (WSN-PN1- Δ-A),  E polar face (WSN-PN1- Δ-E) and a final mutation 
made with both A and E polar face mutations (WSN-PN1- Δ-AE), shown in supplementary 
data (S3).  
The aim of these mutations were to create varying differences in A/California/09 
transmembrane assembly through mutation of polar residues and designed to bring the 
polarity, assembly and strength of interaction of A/California/09 TMD to a similar levels as 
that of A/WSN/33. 
The results of these experimentations (Figure 6) by analysis through confocal microscopy 
revealed that although replacement of the transmembrane domain of primarily spherical 
strain with that of a filamentous strain yielded alterations in morphology and production of 
filamentous VLP’s. Mutations within the A (WSN-PN1- Δ-A), E (WSN-PN1- Δ-E), and both A 
and E face (WSN-PN1- Δ-AE) designed to alter TMD assembly and strength of interaction to 
that N1 and other NA sub types, did not yield any differences in morphology (S1, S2). As 
seen with expression of WSN-PN1 there was formation of filament like structures from all 
polar mutations. Further analysis and scanning of filamentous like formations of WSN-PN1- 
Δ-A, WSN-PN1- Δ-E, WSN-PN1- Δ-AE (Figure 6) revealed no significant differences within 
structure or morphology of formed filament like structures across varying polar mutation 










Analysis of lipid raft formation  
Alterations within the TMD although seemingly able to alter membrane curvature and 
induce budding of filamentous VLP’s, the hydrophobicity of the TMD does not seem to be 
responsible alone for the alterations in morphology. It has previously been shown that 
concentration of lipid raft domains within a virally infected cell play an important role in the 
initiation of membrane curvature by HA and NA14. We hypothesised that mechanisms 
behind filament formation may affect lipid raft formation within the transfected cell, we 
Fig 6: Confocal analysis of HEK 293T cells transfected with pcDNA3.1A myc-his tag plasmids vectors, 
incubated for 48 hours, stained with alexa 488 antibody, fixed and imaged via immunofluorescence 
confocal microscopy. (A) Showing wild type WSN NA (WT WSN) expression forming spherical virions. (B) 
Showing expression of WSN NA with TMD of pandemic 09 strain (WSN-PN1), forming filamentous virus like 
particles. (C) Showing WSN NA with TMD of pandemic 09 strain with alanine substation in the residue 
encoding for the conserved A polar face.(D)showing WSN NA with TMD of pandemic 09 strain with alanine 
substation in the residue encoding for the conserved E Polar face. (E)Showing WSN NA with TMD of 
pandemic 09 strain with alanine substation in the both residues encoding for the conserved A and E polar 
faces. With (C), (D) and (E) forming filament like structures similar in size and morphology to that of WT 
pandemic 09 residue (B)(WSN-PN1) with no significant difference in morphology being found. (F) Showing 




also set out to examine if varying alterations affecting TMD assembly resulted in differences 
in the insertion of TMD into the cell membrane. 
To do this we utilised cholera toxin b subunit, which binds GM1 lipids found in lipid raft 
domains and allows cross linking with a fluorescent antibody to stain transfected cells after 








Fig 7: Confocal imagery of lipid raft formation by transfection of plasmid vectors both WT and TMD 
mutations into 293T HEK cells, incubated for 48 hours and stained with alexa 488 fluorescently 
labelled cholera toxin B crosslinked antibody, imaged through confocal microscopy. (A) Lipid raft 
staining of WT WSN NA Showing dense staining of lipid raft domains toward out membrane, with 
strong puncta like staining seen on surface cell. Scale bar represents 22µm.  (B)Lipid raft staining of 
WSN-PN1, showing diffuse level of staining with stronger localisation of lipid raft domains on out 
cell membrane, but centrifugal pattern of intracellular staining with cell cytoplasm. Scale bar 
representing 14µm. (C) Lipid raft staining of WSN-PN1-Δ-A, showing two types of observed pattern 
of staining. High intensity localised staining in cell membrane, budding filaments and localised 
areas within the cytoplasm of transfected cell. The other observed pattern being similar to WSN-
PN1 with more diffuse intracellular staining and more intense staining on cell membrane. Scale bar 
representing 18µm. (D) lipid raft staining of WSN-PN1- Δ-E, showing a conserved pattern of diffuse 
intracellular staining, with more concentrated staining on the cell surface. Scale representing 
13µm. (E) Lipid raft staining of WSN-PN1- Δ-AE, Showing similar results to that of WSN-PN1 and 
WSN-PN1- Δ-E with wide spread intracellular staining and more concentrated lipid raft formation 
on cell membrane and budding filaments. Scale bar representing 20µm. (F) lipid raft staining of 
empty vector pcDNA3.1A (Invitrogen) control, scale bar representing 20µm.  
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Examination of lipid raft formation (Figure 7) revealed several differences in raft formation 
amongst WT and varying mutations. WT NA showed distinct localisation of raft formation 
within puncta formations within the plasma membrane. NA mutants WSN-PN1- Δ-E, PN1-
WSN- Δ-AE showed similar levels of raft localisation both within filament formations from 
the plasma membrane and significant intracellular staining of lipid raft domains. WSN-PN1- 
Δ-A showed two distinct levels of raft formation, one similar to that of WSN-PN1- Δ-E and AE 
mutations. The other with significant higher levels of staining and raft formation both in 
budding filaments and intracellularly, in a centrifugal pattern towards the cell membrane. 
 
Neuraminidase is capable of causing concentration of lipid raft domains 
Based on various concentration of lipid raft domains (Figure 7) and previous research 5,14 we 
set out to test the current hypothesis that NA is able to concentrate lipid raft domains 
causing creation of these viral budozones and initiating membrane curvature by analysing 
NA’s ability to localise to high lipid areas. Transfected HEK 293T were dual stained with 
antibodies to both lipid raft domains and NA to allow the visualisation of both lipid raft 















Fig 8:  Analysis of co-localisation between lipid raft domains and NA through confocal imagery of HEK 
293T cells that had been transfected with plasmid vectors, incubated for 48 hours and dual stained with  
alexa 488 fluorescently labelled cholera toxin B conjugate to image lipid raft formations (Shown in green). 
And alexa 594 fluorescently labelled donkey anti mouse antibody to image NA (Shown in red) to analyse 
co-localisation of NA and lipid raft domains (Shown in yellow). 
(A)HEK 293T cells transfected with plasmid vector expressing WT WSN NA. Confocal imaging revealing 
circular punctate like areas of co-localisation on cell membrane. Along with expression of NA and lipid raft 
formation both on cell membrane and intracellularly around cell membrane. Scale bar indicating 25µm. 
(B) HEK 293T cells transfected with plasmid vector expressing WSN-PN1 NA. Confocal imaging showing 
extensive co-localisation of NA to lipid raft domains, including extensive co-localisation budding 
filamentous VLP’s. Scale bar indicating 21µm 
(C)HEK 293T cells transfected with plasmid vector containing WSN-PN1- Δ-A NA. Confocal imaging 
revealing extensive co-localisation of NA to lipid raft domains around cell membrane and in budding 
filamentous VLP. Also showing extensive co-localisation of NA and lipid raft domains within cytoplasm of 
transfected cells. Scale bar representing 15.4µm 
(D) HEK 293T cells transfected with plasmid vector containing WSN-PN1- Δ-E NA. Confocal imaging 
revealing extensive co-localisation of NA and lipid raft domains. Also intracellular co-localisation, along 
with significant expression shown by large volume of red staining similar to that of WSN-PN1(with 
unmutated A/CAL/09 TMD) possibly indicating similar insertion and hydrophobic interaction to that of 
WSN-PN1. 
(E) HEK 293T cells transfected with plasmid vector containing WSN-PN1- Δ-AE NA. Confocal imaging 
showing both co-localisation on cell membrane and intracellularly similar to that of WSN-PN1, but with 
more extensive localisation of NA and lipid raft domains on cell membrane. 
(F) HEK 293T cells transfected with empty pcDNA3.1A plasmid vector as a control. Showing no NA and 









The results (Figure 8) showed that both spherical WT WSN NA and filamentous producing 
mutants showed strong indication and evidence of co-localisation staining between NA and 
lipid raft formation.  This experiment also further showed the diffuse pattern of staining 
seen previously (Figure 7), with WT WSN NA demonstrating dotted puncta like staining.  
 WSN-PN1- Δ-A, -E, and –AE showing diffuse intracellular staining and more intense staining 
within the plasma membrane and high localisation within forming filaments, as well as a 
strong presence of co-localisation of NA and lipid rafts intracellularly.  Compared to WSN-
PN1 which showed co-localisation of NA and lipid raft domains, but very little intracellular 
co-localisation, as well as significantly cells lipid raft formation within the transfected cells. 
 
 
The ability of NA to facilitate membrane scission and the release of budding virus like particles 
NA is seemingly able to produce both filamentous and spherical VLP’s when transfected in 
HEK 293T cells. Previous work form our laboratory has indicated to some extent that viral 
proteins such as HA when transfected in a VLP and examined through transmission electron 
microscopy (TEM) are able to seemingly facilitate membrane scission and release budded 
VLP’s ( Dr J Rossman, personal communication, May 2014) in the supernatant of transfected 
cells (data not shown).  
Although it is unknown if NA is able to induce membrane scission of budding virions 
especially filamentous virions or virus like particles.  This is partly due to the process of 
purification required for the analysis of supernatant under TEM, this is due to fragility of 
filamentous VLP’s, which under the required concentrations result in destruction of 
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filamentous structures and leading to formation of artefacts and inconclusive data as shown 
in supplementary figure 4 (S4). 
To overcome this supernatant and cell lysate were taken from HEK 293T cells that had been 
transfected with plasmid vectors WT WSN, WSN-PN1, WSN-PN1- Δ-A, WSN-PN1- Δ-E, WSN-
PN1- Δ-AE and incubated for 48 hours. Examined western blot with the aim to analyse NA 
levels in the cell supernatant under the hypothesis that if NA was able to facilitate 
membrane scission, and release of VLP’s there would be significant release of NA, with the 


















The result of this experiment (Figure 9) showed expression of NA within the cell lysate 
confirming NA within the transfected cell and what had been seen previously through 
confocal analysis. Analysis of cell supernatant revealed partial staining or sheet of staining 
when imaged revealing no conclusive evidence of VLP release within the cell supernatant, 
which as shown in supplementary data (S5) is repeatedly seen.  
Fig 9: Comparison of NA levels within the supernatant and cell lysate of 
transfected HEK 293T cells. Break down as follows lanes 1 and 15 showing 
sea blue 2 prestained ladder (Novex). Lanes 2 to 8 showing samples taken 
from cell supernatant, showing expression of WT WSN(2) and (3), WSN-
PN1(4) and (5), WSN-PN1- \Delta-A (6), WSN-PN1- \Delta-E(7), WSN-PN1- 
\Delta-AE (8). Untransfected HEK 293T control sample (9). 
Lanes 10 to 14 show samples taken from cell lysate, WT WSN cell lysate (10), 
WSN-PN1 cell lysate(11), WSN-PN1- \Delta-A cell lysate (12), WSN-PN1- 
\Delta-E cell lysate(13), WSN-PN1- \Delta-AE cell lysate (14).  
Cell lysate as shown in lanes 10 to 14 shows expression of NA as expected 
from confocal analysis. Cell supernatant shows no distinctive pattern of 
banding indicating either an issue with purification and concentration of 




Loss of neuraminidases enzymatic head domain results in alteration of virus like particle 
morphology 
Alterations within the transmembrane domain as shown can result in changes in VLP 
morphology causing the production of filamentous VLP’s (figure 4 and 5). It is also thought 
that alteration in polarity and structure of NA result in changes amongst assembly of TMD, 
which in turn results in changes to assembly of NA and its insertion into plasma 
membrane30,31.  
The exact mechanism behind NA’s ability to create both filamentous virion and virus like 
particles is currently unknown14. We hypothesised that filamentous VLP formation may be 
dictated by either the activity or the structure of enzymatic head domain or possibly 
through the insertion of the TMD and its interactions with the plasma membrane. 
To test this we utilised a series of plasmid constructs NA76- ΔeltaG+1.3 pcDNA kindly 
produced by R Daniels at University of Stockholm. These plasmids contained only a 76 
amino acid ectodomain containing variable stalk length but missing the enzymatic head 
region (Figure S6). These plasmids consisted of WT WSN-PN1  as seen previously and several 
other plasmids which has been created with amino acid substitutions and replacements 
within the highly conserved N terminus or cytoplasmic tail. These mutations consisted of 
varying deletions and substitutions with the N terminus as illustrated in supplementary data 
(Figure S6).The aim of this was to image and compare the expression and localisation of 
NATMD to assess if even with mutations within the cytoplasmic tail (CT) the TMD is able to 
facilitate insertion into the plasma membrane. The other aim of this experiment was to see 














The results of this experiment showed (Figure 10) that seemingly even with mutations 
within the CT of NA the TMD is able to insert and be expressed within the plasma 
Fig 10: Confocal images of comparison of TMD insertion and alterations to morphology of WSN-
PN1 and M(B), MK(C), MAK(D) and MAA(E) cytoplasmic tail mutations expressed in HEK 293T cells, 
transfected and incubated for 48 hours and stained with alex 488. 
(A)HEK 293T cells transfected with plasmid vector expressing WSN-PN1 NA containing only the 
cytoplasmic tail (CT), TMD and stalk domain of WSN-PN1 NA. Showing expression of NA both 
intracellularly and with evidence of insertion of NA in the plasma membrane of transfected cells, 
no evidence of budding either spherical or filamentous noted 
(B) HEK 293T cells transfected with plasmid vector expressing WSN-PN1 NA (M) with deletion of 
cytoplasmic tail containing only a singular Methionine (M) residue. Showing successful insertion of 
NA into plasma membrane and expression but no evidence of membrane scission of budding. 
(C) HEK 293T cells transfected with plasmid vector expressing WSN-PN1 NA (MK) with residue 
deletions within the CT, containing only M and Lysine (k) residues. Showing successful insertion of 
NA, but with comparable levels of budding to that of M and WSN-PN1 mutants. 
(D) HEK 293T cells transfected with plasmid vector expressing WSN-PN1 NA (MAK) substitutions of 
CT residues 2-4 with alanine residues (MAK). With comparable levels of insertion to that of M, MK 
mutations. 
(E) HEK 293T cells transfected with plasmid vector expressing WSN-PN1 NA (MAA) with 
substitutions of CT residues 2-5 with alanine residues. With comparable levels of insertion to that 
of M, MK mutations, although a small proportion transfected cells expressed higher amount of 
intracellular staining compared to other mutations imaged. 
(F) Control sample showing empty vector pcDNA3.1A transfected in HEK 293T cells under same 











membrane of transfected cell, with no comparable differences in expression between WT 
CT and various mutations being noted. 
The results also showed that despite the TMD is able to insert and be expressed within the 
cell membrane of transfected cells, there was a loss of filament morphology across all the 
transfected cells including WT WSN-PN1 and varying CT mutations (Figure S6). Although 
there is evidence of puncta like staining the lack of bulging of membrane as previously 
shown when spherical budding occurs suggest a lack of budding and alteration of 
membrane curvature. This indicates that the enzymatic head domain may be responsible for 
















In this research project we researched the role of NA in the process of budding and its 
involvement in virion and VLP morphology. More specifically the role the TMD of NA has on 
membrane curvature and the assembly of NA. 
Neuraminidase transmembrane domain may possess conversed features which influence virus 
morphology 
The current mechanisms behind budding of the influenza A virus are currently unknown. 
The current model of budding14 suggest that it is a multi-step process that relies on the 
interactions of several of viral proteins NA, HA, NP, M1 and M2 to facilitate the assembly 
and production of mature influenza virions. In terms of the production of either filamentous 
or spherical virions many of the main viral proteins have been implicated in influencing virus 
morphology such as  M225,34,35, NA and HA5,13,23,24, M121,22.  
Our research has shown that NA taken from either a virus with primarily spherical or 
filamentous morphology, conserves this morphology when expressed in a VLP system 
(Figure 4). When examined further (Figure 5) we have shown the TMD of primarily 
filamentous strain such as that of A/California/09 when substituted into a primarily 
spherical producing NA results in alteration in morphology and the production of primarily 
filamentous VLP’s.  
The ability of the TMD to alter morphology may be due several possible reasons, one is that 
the TMD has been implicated in the assembly of NA through anchoring NA to membrane 
during assembly31. It could be through this anchoring of the ectodomain to the plasma 
membrane that allows a stable platform of which NA to fully assembly. Depending on the 
strength and stability of this binding dictated by the properties of the TMD, could in turn 
alter the physical properties and strength of assembly of the enzymatic head domain and 
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variable stalk region. This difference in assembly could lead to structural difference such as 
differing structural and enzymatic activity. 
Another possibility is that the structure of the TMD it’s self and the insertion of the TMD 
into the plasma membrane may mediate the membrane curvature needed to initiate the 
formation of filamentous virions. 
Previous research 30,31 has shown the structure of the transmembrane domain more 
specifically the position of various polar faces within the structure of the TMD leads to 
alterations in the polar activity and ultimately the hydrophobicity of the TMD (S1,S2). 
Leading to varying differences in the strength of interaction between the TMD and the 
plasma membrane. This strength of reaction may also dictate whether the TMD is able to 
insert and interact strongly enough to initiate membrane curvature and stabilise the 
budding virion to allow the production of filaments. Although our experiments showed that 
when transfected in a VLP system, NA containing only the CT, TMD and variable stalk region 
is not sufficient to induce membrane curvature, but shows no conclusive evidence of VLP 
production. This may be due the TMD it’s self not being solely responsible for the alteration 
of membrane curvature and VLP production, NA may require the enzymatic head domain or 
full NA structure in order to insert into the membrane with the required force to generate 
sufficient membrane curvature. This may be also due to the lack of enzymatic head domain, 
as it is required for the concentration of lipid raft domains in the plasma membrane and the 
theorised first step and initiation the  of budding process. The lack of the enzymatic head 
domain and loss of concentration of lipid raft domains likely meant that as this 
concentration of lipid was missing, the initial alteration in membrane curvature thought to 
be required for the start of the budding process was absent. Assuming this lipid raft 
concentration if required, it is possible that the insertion of the TMD into the plasma 
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membrane relies on this initial curvature in order to generate enough force of which to 
facilitate the primary stages of budding and influence virus morphology.  
Further research is need to elucidate the mechanisms behind which the TMD influences 
morphology into either structural confirmation of NA such as enzymatic activity or in 
regards to the insertion capabilities of NA. At the time of writing, our lab is undertaking a 
data mining project designed to compare the residue structures of the NA TMD’s of 
primarily spherical and filamentous strains and comparing residue differences, alongside 
examining if previous literature has found residue mutations with the TMD which seemingly 
alter the enzymatic activity NA.   
More research is also needed to analyse the effects of the TMD on enzymatic head domain 
to rule out this theory and possibility of alterations. This could be achieved through reverse 
genetic mutations of NA with varying TMD mutations and measuring of enzymatic, and 
crystallography data of NA mutations as well as mapping sequential and functional 
differences within the head domain. 
 
Failure of western blot analysis to determine the ability of neuraminidase to facilitate the 
release of budding virus like particles 
The longest known role of NA is that it is able to cleave sialic acid residues from the cell 
surface of infected cells in order to prevent coagulation of budding virions and facilitate the 
release of mature virions from the cell surface. We hypothesised that because of this in a 
VLP system NA should in theory be able to facilitate the release of VLP provided it can 
induce sufficient membrane curvature to allow pinching off and release of new budding 
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virions. A role that in the release of mature virions in a live model is thought to be facilitated 
by M2. 
Due to previous experimentation through TEM in our laboratory, we found that the 
concentration process required to extract and image cell supernatant for the release of 
filamentous VLP’s resulted in inconclusive data (data not shown). This was thought to be 
due to the fragility of filamentous VLP, with the concentration and processing steps required 
for TEM resulting in the destruction of filamentous VLPs and production of large amounts of 
artefacts providing inconclusive data (S4). 
Despite alteration to methodology for a gentler concentration, our aim to explore NA VLP 
release through analysis of NA in the cell supernatant through western blotting proved to 
also yield largely inconclusive data. This could be due to the concentration and spin 
methodologies used result in the destruction of filaments and improper concentration of 
VLP’s, a step which is currently being tested in our laboratory is the use of a sucrose 
gradient purification system, allowing gentler and more efficient concentration of VLP’s. 
Although the data shows clear expression of NA from the cell lysate, indicating the 
expression of NA in transfected cells, the data shows no conclusive evidence of NA within 
the supernatant of transfected cells. With some sporadic staining seen, but unclear if this 
staining is due to over staining or as a result of the destruction of budding filaments caused 
by the concentration of supernatant, resulting in fragmentation of VLP’s leading to this 
sheet like staining and no clearly defined banding patterns. With these results being 
observed repeatedly through various rounds of concentration and western blot analysis 
(S5).   
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It could also stand to reason that either the level of VLP expression is at low and 
undetectable amount or the concentration level required is beyond the range of current 
concentration and western blot method to allow adequate concentration of sample and 
detection of NA. 
It may also be possible that although NA is able to significantly alter membrane curvature it 
may not generate enough force required to allow the release of budding VLP’s and may 
require the interaction of other viral proteins such as M1 and M2 in order to facilitate 
negative membrane curvature and required force to allow the pinching and release of 
budding virion.    
Further research is needed into the ability of NA to facilitate the release of budding VLP’s 
and the kinetics that required to allow this process to happen.  
 
Neuraminidase enzymatic head domain is seemingly required to facilitate budding in a VLP 
system  
As we have shown NA is seemingly and quite complexly involved in the budding process, the 
exact extent of which is currently unclear. We have shown in this research project that the 
TMD as previously seen 28,29 is able to alter morphology. Although the mechanism of which 
is unclear, our research has shown that when expressed singularly the TMD is not able to 
alter membrane curvature and is seemingly unable to facilitate budding. The formation of 
puncta like staining, but lack of membrane curvature or bulging suggests that TMD alone is 
not able produce spherical or filamentousVLP’s. Although further examination through 
expression and TEM studies is required to complete confirm the absence of spherical VLP’s 
from these experiments. 
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On the surface these results suggest that the enzymatic head domain is required in order to 
facilitate budding. As previously mentioned this may be due to a number of factors such as 
the head domain giving the required strength need by NA to insert effectively into 
membrane or being required to concentrate lipid raft domains to allow budding process to 
begin. Interestingly it may possible that during assembly of NA mediated by the TMD 
alterations within stalk height or ectodomain itself, caused by the TMD may result in 
alterations in the structure and enzymatic activity of NA which results in different 
morphology. 
Neuraminidase is able to strongly localise to lipid raft domains during budding 
The current theory on the process of influenza virus budding and the interactions of viral 
proteins in budding suggests that HA36 and to a lesser extent NA is able to cause the 
concentration of lipids into lipid raft domains, thought to be responsible for the initiation of 
membrane curvature and starting the budding process. Previous studies have suggested 
that NA is able to localise and cause concentration of lipid raft domains although within the 
field there is a significant divide in the exact extent NA is thought to be able to contribute to 
this process 
We have shown (Figure 8) that when expressed in a virus like particle system that NA is able 
to strongly co-localise to lipid raft domains both in the production of filamentous and 
spherical VLP’s.  Providing strong evidence to support the current theory of budding that NA 
is able to localise and concentrate lipid raft domains. 
Our results also showed varying difference in lipid raft interactions particularly amongst NA 
TMD mutants WSN-PN1- Δ-E, WSN-PN1- Δ-AE which showed strong intracellular localisation 
of lipid raft domains. This more intense staining of lipid raft domain both on plasma 
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membrane and intracellularly may be due to the strength of interaction of the TMD with the 
plasma membrane. The differences in polarity, structure and position of the polar faces may 
alter the strength of insertion and interaction of the TMD with membrane due to differing 
hydrophobicity of the TMD as currently thought 30. 
Further research is needed particularly in the area of time lapse confocal microscopy 
examining NA formation and lipid raft concentration, along with examination of raft 
formation and lipid concentration when expressed in NA mutants lacking enzymatic head 
domain will help confirm and provide further evidence of NA’s ability to concentrate lipid 
raft domains.  
Impact of this research project 
Overall this research project produced several key findings which add to the current cannon 
of knowledge surrounding the process of budding and morphology of the influenza A virus. 
We have confirmed that as previously thought NA seemingly doe play a role in morphology 
of the influenza A virus and there is a strong correlation between NA and concentration of 
lipid raft domains supporting the current work around the process of budding. 
We have also shown that the TMD is able to alter morphology, with the TMD seemingly 
being able to conserve and confer filament morphology and that both the both head 
domain and TMD play a role in budding. This research in turn will have an importance in a 
mixture of areas such as pharmaceutical industry more specifically production of seasonal 
influenza vaccine. Where the random production of filamentous virions affects and disrupts 
manufacture and purification of vaccine leading loss of time and money. As well as further 
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S1: Model of Transmembrane domain assembly and the alterations in hydrophobicity 
of TMD conferred by positioning of polar faces. 
Figure S1 is showing assembly of the distinct polar face and there assembled positions 
amongst the varying NA subtypes. NA subtypes N1, N3 – N9 have a conserved 
assembled structure and positioning of polar residues and N2 subtype having differing 
position of polar faces within the assembled transmembrane domain (TMD). The 
assembled structure of TMD and  structural positioning of polar faces leads to alteration 
in the hydrophobicity of TMD thought to alter the strength of which TMD inserts into 
the membrane and alter the strength of binding of NA head domain. Adapted from 


















S2: Schematic of interaction between polar faces of TMD during assembly of 
TMD from a dimer to a tetramer and effect of residue positions. 
Demonstrating current theory that the profile of polar residues present within 
the TMD (1) and there position within TMD assembly from a dimer to a 
tetramer (2), directly alter their positioning within the assembled TMD and the 
differential positioning of residues proportionally effects there interactions 
with the membrane of infected cell during its intersection during assembly of 
budding virion(3). Also suggested that Hydrogen bond formation and 
hydrophobicity of the transmembrane domain are inversely related.  Figure 






















S3: Positioning of alanine substitutions within residues of TMD thought to be responsible for polar faces. 
Showing the positioning of the alanine residue substitutions in critical residues responsible for the 
conserved polar faces.  With sequence data representing plasmids WSN33 (WT WSN NA), hN1 pH1N1 
(WSN-PN1), hN1 pH1N1 D A (WSN-PN1- \Delta-A), hN1 pH1N1 D e (WSN-PN1- \Delta-E), hN1 pH1N1 (WSN-
PN1- \Delta-AE). Figure adapted from Da silva et al 2013 and provided by Robert Daniels, University of 
Stockholm. 
S4: Example of fragmentation and production of artefacts during concentration and imaging for 
TEM analysis. 
Example of the production of filament like fragments caused by the concentration method required 
for TEM analysis. Due to pleomorphic nature of filamentous virus like particles and mature virions 
examination of viral and cell supernatant can be problematic in producing verifiable confirmation of 




















S5: Comparison of NA from transfected cell lysate and cell supernatant.  
Previous repeat of HEK 293T cells transfected with NA plasmid vectors. 
Wells 2 -6 showing cell lysate sample and wells 8-12 showing cell 
supernatant samples.  Lane layout as follows (1) Sea Blue 2 prestained 
ladder (Novex), (2) WT WSN NA, (3) WSN-PN1 NA, (4) WSN-PN1- \Delta-A 
NA cell lysate, (5) WSN-PN1- \Delta-E NA, (6) WSN-PN1- \Delta- AE NA, (7) 
Untransfected control sample of cell lysate. (8) WT WSN NA from cell 
supernatant, (9) WSN-PN1 NA, (10) WSN-PN1- \Delta-A NA, (11) WSN-PN1- 
\Delta-E NA, (12) WSN-PN1- \Delta-AE NA. 
Cell lysate as shown indicates NA from transfected cells. Cell supernatant 
shows the same sheet like back ground staining and no expression or 






S6: Cartoon depiction of amino acid substitutions and deletions with the cytoplasmic tail and deletion 
of ectodomain of NA. 
Figure showing deletions within the cytoplasmic tail and ectodomain region within WSN-PN1 ( WSN NA 
with A/Swine/09 TMD) NA pcDNA3.1A plasmids in order to create the NA76 DG 1.3 pcDNA3.1A plasmid 
constructs used to test the ability of TMD to alter membrane curvature. Showing the various residue 
substitutions need to make MAA, MAK, M MK mutations within the cytoplasmic tail. 
